[HTML][HTML] Fatal anaphylaxis: mortality rate and risk factors

PJ Turner, E Jerschow, T Umasunthar, R Lin… - The Journal of Allergy …, 2017 - Elsevier
Up to 5% of the US population has suffered anaphylaxis. Fatal outcome is rare, such that
even for people with known venom or food allergy, fatal anaphylaxis constitutes less than …

An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions

LH Garvey, DG Ebo, PM Mertes, P Dewachter… - Allergy, 2019 - Wiley Online Library
Perioperative immediate hypersensitivity reactions are rare. Subsequent allergy
investigation is complicated by multiple simultaneous drug exposures, the use of drugs with …

First-dose mRNA COVID-19 vaccine allergic reactions: limited role for excipient skin testing

AR Wolfson, LB Robinson, L Li, AE McMahon… - The Journal of Allergy …, 2021 - Elsevier
Background The Centers for Disease Control and Prevention state that a severe or
immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine is a …

Anaphylaxis in children and adolescents: the European Anaphylaxis Registry

LB Grabenhenrich, S Dölle, A Moneret-Vautrin… - Journal of allergy and …, 2016 - Elsevier
Background Anaphylaxis in children and adolescents is a potentially life-threatening
condition. Its heterogeneous clinical presentation and sudden occurrence in virtually any …

Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label …

E Louis, M Resche-Rigon, D Laharie… - The Lancet …, 2023 - thelancet.com
Background The combination of infliximab and immunosuppressant therapy is a standard
management strategy for patients with Crohn's disease. Concerns regarding the implications …

[HTML][HTML] Guideline on allergen immunotherapy in IgE-mediated allergic diseases: S2K guideline of the German society of allergology and clinical immunology (DGAKI) …

O Pfaar, T Ankermann, M Augustin, P Bubel… - Allergologie …, 2022 - ncbi.nlm.nih.gov
Pneumologists, Sleep and Respiratory Physicians (BdP)(Sebastian Böing), Professional
Association of German Dermatologists (BVDD)(Klaus Strömer) were taking part in the …

Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update: S2k-Guideline of the German Society for Allergology and Clinical Immunology …

J Ring, K Beyer, T Biedermann, A Bircher… - Allergo journal …, 2021 - Springer
Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update | Allergo
Journal International Skip to main content SpringerLink Account Menu Find a journal Publish …

Factors increasing the risk for a severe reaction in anaphylaxis: An analysis of data from The European Anaphylaxis Registry

M Worm, W Francuzik, JM Renaudin, MB Bilo… - Allergy, 2018 - Wiley Online Library
Background Preventive measures to decrease the frequency and intensity of anaphylactic
events are essential to provide optimal care for allergic patients. Aggravating factors may …

[HTML][HTML] Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management

D Rampton, J Folkersen, S Fishbane, M Hedenus… - …, 2014 - ncbi.nlm.nih.gov
Intravenous iron is widely used for the treatment of iron deficiency anemia when oral iron is
inappropriate, ineffective or poorly tolerated. Acute hypersensitivity reactions during iron …

Clinical features and severity grading of anaphylaxis

SGA Brown - Journal of Allergy and Clinical Immunology, 2004 - Elsevier
BACKGROUND: Existing grading systems for acute systemic hypersensitivity reactions vary
considerably, have a number of deficiencies, and lack a consistent definition of anaphylaxis …